Science Prevails Over Profit Motive!

As you’ll read all over, the FDA unanimously denied approval for Flibanserin.

I followed the day’s proceedings via The New View Campaign’s twitter feed from inside the meeting. It was amazing stuff. The result is not an unmitigated success because the committee apparently expressed support for the IDEA of a drug for sexual desire and the HSDD diagnosis, but felt the drug in question had not provided adequate evidence of benefit against risk.

Be that as it may, Petra Boynton noted that she was celebrating the defeat of Flibanserin with this video:

It pretty much captures how I feel too.